Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Baseline MxA mRNA Expression Predicts Interferon Beta Response in Multiple Sclerosis Patients.
Regulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation.
[Cormorbidity in multiple sclerosis and its therapeutic approach].
Relative incidence of inherited white matter disorders in childhood to acquired pediatric demyelinating disorders.
Epidemiology of neurologically disabling disorders.
[The effect of tobacco smoking on clinical effectiveness of immunomodulatory treatment in multiple sclerosis patients].
[Indexes of integrative activity of motor system in norm and at neuromotor pathology].
Demographic and clinical factors associated with changes in employment in multiple sclerosis.
Longitudinally Extensive Varicella-Zoster Virus Myelitis in a Multiple Sclerosis Patient.
Clinical improvement precedes lesion size regression in a severe case of acute disseminated encephalomyelitis.
Correlation between blink reflex abnormalities and magnetic resonance imaging findings in patients with multiple sclerosis.
16 Syndrome in a Patient With Multiple Sclerosis.
Myelin water mapping by spatially regularized longitudinal relaxographic imaging at high magnetic fields.
Targeting endothelial CD146 attenuates neuroinflammation by limiting lymphocyte extravasation to the CNS.
Apoptosis of oligodendrocytes in the central nervous system results in rapid focal demyelination.
Neurogenic detrusor overactivity is associated with decreased expression and function of the large conductance voltage- and ca(2+)-activated k(+) channels.
Is total duration of distal compound muscle action potential better than negative peak duration in the diagnosis of chronic inflammatory demyelinating polyneuropathy?
Subcutaneous Interferon β-1a May Protect against Cognitive Impairment in Patients with Relapsing-Remitting Multiple Sclerosis: 5-Year Follow-up of the COGIMUS Study.
Clinical features of patients with Guillain-Barré syndrome at seven hospitals on the East Coast of Australia.
Therapeutic plasma exchange in children with acute autoimmune central nervous system disorders.
Innovative quantitative testing of hand function in Charcot-Marie-Tooth neuropathy.
The Keap1/Nrf2 pathway in health and disease: from the bench to the clinic.
Progressive resistance therapy is not the best way to rehabilitate deficits due to multiple sclerosis: Commentary.
A randomized, controlled trial of fingolimod (FTY720) in Japanese patients with multiple sclerosis.
Advances in the pharmacological and neurological treatment of patients with multiple sclerosis.

Pages